[Skip to Content]
[Skip to Content Landing]
February 10, 1969

Treatment of Hemorrhagic Disorders

Author Affiliations

University of Illinois Chicago

JAMA. 1969;207(6):1153. doi:10.1001/jama.1969.03150190075026

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Since there have been at least ten other books on bleeding and coagulation disorders published in the 60's, one might well ask, "Why another?" Several answers are forthcoming: (1) Some facets of specific therapy, such as the use of cryoprecipitated antihemophilic factor in classic hemophilia, the use of heparin in defibrination syndromes, and the use of epsilon aminocaproic acid in primary systemic fibrinolysis, are sufficiently recent in development that modern usage of these agents is not adequately described in other volumes. (2) Practical details of nonspecific management are often given short shrift. (3) Books of this nature generally give strong emphasis to details of laboratory methodology; there is need for a concise guide to the clinician who sees occasional patients with bleeding and coagulation disorders but who does not have access to a sophisticated coagulation laboratory. (4) Some volumes focus on a particular category of bleeding disorder rather than encompassing